Sentence examples for mice conferred significant from inspiring English sources

Adoptive transfer of CD8 T cells, alone or together with CD4 T cells or natural killer cells, from LV305-immunized donor mice to tumor-bearing recipient mice conferred significant protection against metastatic tumor growth.

Furthermore, adoptive transfer of purified MDSCs into naïve mice conferred significant protection from ConA-induced hepatitis.

Furthermore, injection of SIRT1 lentivirus in the hippocampus of p25 transgenic mice conferred significant protection against neurodegeneration (Kim et al, 2007).

Passive serum antibody from M2 prime boost immune mice also conferred significant protection against weight loss.

Passive transfer of J8-DT antiserum/antibodies from mice and rabbits conferred significant resistance against challenge to mice.

Moreover, nasal immunization of mice with PspA5-wP conferred significant protection against nasopharyngeal colonization of mice with the 0603 pneumococcal strain, (P = 0.003; 0.01 and 0.001, when comparing PspA5-wP vaccinated mice with non-immunized mice, or mice immunized with wP or PspA5, respectively) (Figure 5C).

Blood glucose levels of mice were followed weekly and the percentage of mice developing hyperglycemia is shown in Figure 2. Treatment with DC/sIL-4 conferred significant protection (p≤0.05 using the log-rank test) with 50% of mice treated with DC/sIL-4 developing diabetes by 30 weeks as compared to >90% of saline-treated mice.

Therefore, in addition to improved muscle histology, genetic ablation of CCR2 conferred significant functional benefits upon the muscles of mdx mice.

Antibody-mediated in vivo neutralization of IFN-γ or targeted disruption of IFN-γ gene conferred significant protection from lethal TSS in HLA-DR3 transgenic mice.

Prophylactic administration of HMGB1-specific neutralising antibody conferred significant protection against hepatic I R injury in wild-type mice, but not in a TLR4-defective (C3H/HeJ) mutant, implicating TLR4 in HMGB1-mediated hepatic I R injury (Ref. 99).

In comparison, only 8 of 17 galectin-3-KO mice (47%) developed symptoms of ECM by day 8 post-infection, indicating that loss of galectin-3 conferred significant (p<0.0073, Fisher's exact test) protection from ECM.